MDMA-assisted therapy just made the front page of the NY Times. Psilocybin-assisted therapy was featured on 60 Minutes. So if your patients haven’t already started asking about psychedelics, they will soon.
And what will you say? Or perhaps the bigger question is: what can you *legally* say?
That’s why we’ve assembled a panel of legal experts in the psychedelic field to answer the myriad of questions you may have regarding what you can and can’t discuss with patients about these substances that are still illegal federally.
From the legality of discussing illegal substances to whether clinicians can refer to psychedelic therapists, our legal experts are here to answer your questions as we collectively enter a new frontier in medicine. There will be ample time for audience Q and A at the end, so you’ll get to interact with the panelists directly!
So please join us for this live panel discussion on Thursday, May 27th at 5 pm Pacific, 8 pm Eastern. This is exclusively for members of the Psychedelic Medicine Association, so if you have not yet registered, please do so here. And for members, please register for the panel here. A link to the recording will be available afterward if you cannot make it to the live event.
Hope to see you all on the 27th!


